Given that the expression levels of FCGR3A and FGL2 exhibit similar trends across different subtypes of gliomas and the anatomical localization is the same in tumor, we propose that FCGR3A and FGL2 co express on a type of cell within gliomas. Here, FCGR3A is linked to central nervous system cancer.